← Back to guidelines
Dermatology191 papers

Esophageal ulcer caused by aspirin

Last edited: 4/14/2026

Overview

Esophageal ulcers caused by aspirin typically arise due to direct mucosal injury from the drug's irritant properties, often exacerbated by factors like reduced esophageal motility or concurrent use of other irritant medications. 1

Diagnosis

  • Clinical Presentation: Symptoms include dysphagia, retrosternal pain, and potential bleeding.
  • Endoscopy: Essential for visualizing ulceration and excluding other causes.
  • Temporal Relationship: Strong association with recent aspirin use or other irritant medications. 145
  • Management

  • First-Line Treatment:
  • - Proton Pump Inhibitors (PPIs): Omeprazole 40 mg daily has shown efficacy in healing ulcers. 2
  • Adjunctive Measures:
  • - Avoidance of Irritants: Discontinue or switch from irritant medications like aspirin and tetracycline when possible. 145 - Hydration: Ensure patients take medications with adequate water and avoid nighttime dosing. 45

    Special Populations

  • Comorbidities: Patients with esophageal motility disorders or strictures are at higher risk and require careful management to avoid complications. 45
  • Key Recommendations

  • Initiate Proton Pump Inhibitor Therapy for esophageal ulcers associated with aspirin use to promote healing. (Evidence: Moderate 2)
  • Avoid Concurrent Use of Irritant Medications such as tetracycline and doxycycline, especially in patients with esophageal abnormalities. (Evidence: Weak 45)
  • Advise Proper Medication Administration including sufficient water intake and timing to minimize esophageal irritation. (Evidence: Expert opinion)
  • References

    1 Zheng W, Jin LY, Hu J, Wang JY, Mao KL, Jiang Q. Signal detection of drug-induced esophageal ulcer across 20 years of real-world study: Focus on 49 high-risk medicines. The Journal of international medical research 2026. link 2 Gimson A, Polson R, Westaby D, Williams R. Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy. Gastroenterology 1990. link90495-m) 3 Ramboer C, Verhamme M. D-penicillamine-induced oesophageal ulcers. Acta clinica Belgica 1989. link 4 Khera DC, Herschman BR, Sosa F. Tetracycline-induced esophageal ulcers. Report of two cases. Postgraduate medicine 1980. link 5 Crowson TD, Head LH, Ferrante WA. Esophageal ulcers associated with tetracycline therapy. JAMA 1976. link

    Original source

    1. [1]
      Signal detection of drug-induced esophageal ulcer across 20 years of real-world study: Focus on 49 high-risk medicines.Zheng W, Jin LY, Hu J, Wang JY, Mao KL, Jiang Q The Journal of international medical research (2026)
    2. [2]
      Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy.Gimson A, Polson R, Westaby D, Williams R Gastroenterology (1990)
    3. [3]
      D-penicillamine-induced oesophageal ulcers.Ramboer C, Verhamme M Acta clinica Belgica (1989)
    4. [4]
      Tetracycline-induced esophageal ulcers. Report of two cases.Khera DC, Herschman BR, Sosa F Postgraduate medicine (1980)
    5. [5]
      Esophageal ulcers associated with tetracycline therapy.Crowson TD, Head LH, Ferrante WA JAMA (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG